Hims & Hers is a fantastic value despite its high on-the-surface P/E ratio and valuation metrics. Click here to read why HIMS ...

We recently compiled a list of the 10 Best Hair Care Stocks To Buy Now. In this article, we are going to take a look at where ...

U.S. telehealth company Hims & Hers Health on Wednesday said it will sell compounded versions of Novo Nordisk's popular ...

Hims & Hers Health (HIMS -3.66%) has built its brand up in recent years by focusing on offering its customers products ...

In the latest market close, Hims & Hers Health, Inc. (HIMS) reached $16.44, with a +0.86% movement compared to the previous day. The stock exceeded the S&P 500, which registered a gain of 0.28% for ...

Buying a new pharmacy will allow Hims & Hers to expand into new markets. Hims & Hers ( HIMS -1.11%) recently acquired a ...

Hims & Hers Health will offer compounded GLP-1 weight-loss medications for as low as $99 per month to eligible U.S. military ...

Needham has recently initiated Hims & Hers Health Inc (HIMS) stock to Buy rating, as announced on August 22, 2024, according to Finviz. Earlier, on August 9, 2024, Imperial Capital had reduced the ...

Hims & Hers Health, Inc. ("Hims & Hers", NYSE: HIMS), the leading health and wellness platform committed to breaking down ...

Hims & Hers, the telehealth company, saw its stock price range from under $6 to over $25 during the last 52 weeks. Click here ...

Check the time stamp on this data. Updated AI-Generated Signals for Hims & Hers Health Inc. Class A (HIMS) available here: ...

Adam Spatacco has positions in Eli Lilly and Novo Nordisk. The Motley Fool has positions in and recommends Pfizer, Target, and Teladoc Health. The Motley Fool recommends Johnson & Johnson, Moderna, ...